11/12 Pharmadynamics Flashcards

1
Q

what is pharmacodynamics?

A

the drugs effects on the body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the five different types of biochemical receptors

A
  1. Intracellular. 2. Ligand-regulated enzyms. 3. Cytokine 4. ligand-gated ion channel. 5. G-protien linked
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

describe an intracellular biochemical receptor

A

a receptor that will bind a lipophilic drug or other drug that enters the cell and binds in the cytoplasm.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

describe a ligand regulated enzyme

A

this is a receptor that will bind a ligand on the outside of the cell and then on a transmembrane component: cause a conformational change or other change in the receptor that will turn it into a an active enzyme on the intracellular portion of the receptor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

describe a cytokine biochemical receptor:

A

receptor binds the drug, causing the receptor to bind a ligand on the intracellular portion and then the intercellular portion will act to phosphorilate intracellular molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe ligand-gated ion channel biochemical receptors:

A

they bind a ligand or other drug that will cause the ion channel to open and allow ions to flow through

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe G-protein coupled biochemical receptors:

A

they are7 transmembrane receptors, interact with a G-protien and have an effector element and second messenger.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the possible effector elements of a G-protein?

A

Enzymes (protien kinase A) or ion channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the second messengers of G proteins

A

cAMP, IP3 and cGMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Non-superimposable mirror images of a drug:

A

Chiral molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

why would chirality be important for drug delivery?

A

50% of useful drugs have different chrality with different potentcy or toxicity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Most common drug-receptor interactions use what type of bond?

A

Electrostatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

a drug that binds a physicologic receptor and mimics the regulatory effects of the endogenous signaling compounds

A

Agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

partial agonist

A

binds and activates the receptor but does not evoke as great a response as full agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Allosteric agonist

A

binds to a site on the receptor remote from the agonist binding site.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Inhibiting drug action

A

mimics agonist drugs by inhibiting the molecules responsible for terminating the action of an endogenous agonist

17
Q

inverse agonist drug action

A

reduces receptor activity below basal levels observed in the absence of bound ligand (clinical effets similar to competitive antagonist)

18
Q

The level of response vs. log of the drug conc. for a full agonist; partial agonist , inactive compound, and inverse agonist.

A
19
Q

a drug without regulatory effect that interferes with the ability of the endogenous agonist to activate a receptor

A

Antagonist

20
Q

Describe Reversible competitive antagonists

A

reversibly binds to the same site as the agonist. Increases the agonist concentration required for a given degree of response.

21
Q

Irreversibly binds the same site as the agonist. Reduces the maximal effect the agonist can achieve

A

Allosteric

22
Q

What types of antagonist are non-Competitvie

A

Irreversible;

Allosteric;

23
Q

Graph of a competitive antagonist

% max effect vs. Log [drug] as you add more and more antagonist

A
24
Q

Graph of Non-competitive Antagonist in the form of irreversible antagonist:

% max effect vs. [drug] for different amounts of antagonism added

A
25
Q

Graph of Non-competitive Antagonist in the form of Allosteric antagonist:

% max effect vs. [drug] for different amounts of antagonism added

A
26
Q

What is the concentration of drug where 50% effect has been achieved?

A

the EC50 or effective concentration 50

27
Q

What is the difference in potency vs. efficacy?

A

the potency is the conc. of drug needed to be able to reach % max effect

(greater conc. needed then less potency– look at the right shift in the % effect vs. log[] graph – farther to the right the less potent)

The Efficacy is the ability of the drug to reach a high % effect.

(less % effect reached at high conc. then less efficacy – look at the hight of the final equilibrium of the % effect vs. Log [] graph – smaller height is less efficacy)

28
Q

The graphical representation of the ED-50 dose and the LD-50 dose

A
29
Q

The dose at which 50% of individuals exhibit the specified effect

A

Median effective dose (ED-50)

30
Q

I’m prescribing a drug, and I want to know how likely a high dose of the drug is going to kill by patient…given that I work with an average patient that is :-) what do I want to calc?

A

the Therapeutic Index

TI = TD-50/ED-50 or TI = LD-50/ED-50

where TD=toxic dose; LD = lethal dose; ED=Effective dose

as the number gets smaller, and closer to one, then the drug is more likely to cause problems with any kind of large dose!

31
Q

The dose at which 50% of the individuals exhibit the specified toxic effect

A

Median toxic dose (TD-50)

32
Q

Median Lethal dose (LD-50)

A

the does at which 50% of the individuals die

33
Q

hmmm, the patient just had a really infrequent reaction to the drug…what kind of variability is this?

A

Idiosyncratic variability

34
Q

This person just does not have a very intense effect from this dose of the drug that most people see a large effect from…what do I call this?

A

Hyporeactive

35
Q

This perosn has a very intense effect from this drug that most have a mild effect…what do I call this variability

A

Hyperreactive

36
Q

This person takes this drug every day and now it doesn’t seem to effect them at all….?

A

Tolerance

37
Q

The intensity of response is rapidly diminshed in response to continued drug administraition?

A

Tachyphylaxis

38
Q
A